Edward Agyare

532 total citations
22 papers, 378 citations indexed

About

Edward Agyare is a scholar working on Oncology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Edward Agyare has authored 22 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 12 papers in Biomaterials and 7 papers in Biomedical Engineering. Recurrent topics in Edward Agyare's work include Nanoparticle-Based Drug Delivery (12 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Nanoplatforms for cancer theranostics (5 papers). Edward Agyare is often cited by papers focused on Nanoparticle-Based Drug Delivery (12 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Nanoplatforms for cancer theranostics (5 papers). Edward Agyare collaborates with scholars based in United States and Cameroon. Edward Agyare's co-authors include José G. Treviño, Sunil Krishnan, Bo Han, Felix Amissah, Sunil Krishnan, Edward Ofori, Patrick W. Underwood, Jens T. Rosenberg, Mandip Singh and Mandip Sachdeva and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Edward Agyare

20 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward Agyare United States 11 201 127 109 106 68 22 378
Mukesh Ukawala India 7 204 1.0× 123 1.0× 98 0.9× 119 1.1× 66 1.0× 9 379
Pallavi Chand India 8 149 0.7× 127 1.0× 46 0.4× 139 1.3× 62 0.9× 10 364
Bingxiang Zhao China 11 223 1.1× 141 1.1× 82 0.8× 214 2.0× 52 0.8× 18 440
Adem Şahin Türkiye 11 208 1.0× 117 0.9× 44 0.4× 134 1.3× 101 1.5× 22 411
Wei-Lun Tang Canada 9 219 1.1× 176 1.4× 69 0.6× 146 1.4× 59 0.9× 10 443
Nikhil Rai India 11 122 0.6× 117 0.9× 53 0.5× 149 1.4× 34 0.5× 21 359
Pasupathi Sundaramoorthy United States 13 139 0.7× 105 0.8× 66 0.6× 209 2.0× 50 0.7× 17 445
Noor Alam India 13 298 1.5× 153 1.2× 140 1.3× 225 2.1× 79 1.2× 14 574
Emilienne Soma France 6 251 1.2× 112 0.9× 94 0.9× 149 1.4× 53 0.8× 7 361
Vasanthakumar Sekar India 7 102 0.5× 83 0.7× 58 0.5× 141 1.3× 72 1.1× 15 327

Countries citing papers authored by Edward Agyare

Since Specialization
Citations

This map shows the geographic impact of Edward Agyare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Agyare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Agyare more than expected).

Fields of papers citing papers by Edward Agyare

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Agyare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Agyare. The network helps show where Edward Agyare may publish in the future.

Co-authorship network of co-authors of Edward Agyare

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Agyare. A scholar is included among the top collaborators of Edward Agyare based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Agyare. Edward Agyare is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Shuqing, et al.. (2025). ECM Stiffness-Induced Redox Signaling Enhances Stearoyl Gemcitabine Efficacy in Pancreatic Cancer. Cancers. 17(5). 870–870. 2 indexed citations
2.
Yoon, Saunjoo L., Oliver Grundmann, Judith M. Schlaeger, et al.. (2025). Cachexia in Pancreatic Cancer: New Insights to Impact Quality of Life and Survival. Nutrients. 17(19). 3064–3064.
3.
Bulusu, Raviteja, et al.. (2024). Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-vitro evaluation against pancreatic cancer. European Journal of Pharmaceutical Sciences. 196. 106754–106754. 4 indexed citations
4.
Bulusu, Raviteja, et al.. (2023). Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer. BMC Cancer. 23(1). 435–435. 7 indexed citations
5.
Bulusu, Raviteja, et al.. (2023). Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer. International Journal of Molecular Sciences. 24(5). 4288–4288. 6 indexed citations
6.
DeRemer, David L., Edward Agyare, John M. Allen, et al.. (2023). Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans. Journal of the National Medical Association. 115(2). 164–174. 3 indexed citations
7.
Bulusu, Raviteja, et al.. (2022). Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer. BMC Cancer. 22(1). 1345–1345. 2 indexed citations
8.
Agyare, Edward, et al.. (2021). Multi-disciplinary Approach for Drug and Gene Delivery Systems to the Brain. AAPS PharmSciTech. 23(1). 11–11. 30 indexed citations
9.
10.
11.
Zhu, Xue Y., Patrick W. Underwood, Sunil Krishnan, et al.. (2020). Enhancing efficacy of gemcitabine in pancreatic patient-derived xenograft mouse models. International Journal of Pharmaceutics X. 2. 100056–100056. 12 indexed citations
12.
Han, Bo, et al.. (2020). Application of smart solid lipid nanoparticles to enhance the efficacy of 5-fluorouracil in the treatment of colorectal cancer. Scientific Reports. 10(1). 16989–16989. 71 indexed citations
13.
Ofori, Edward, et al.. (2019). Cytotoxic effects of gemcitabine-loaded solid lipid nanoparticles in pancreatic cancer cells. Journal of Drug Delivery Science and Technology. 55. 101374–101374. 50 indexed citations
14.
Scarton, Lisa, Saunjoo L. Yoon, Sungho Oh, et al.. (2018). Pancreatic Cancer Related Health Disparities: A Commentary. Cancers. 10(7). 235–235. 29 indexed citations
15.
Agyare, Edward, et al.. (2018). Evaluation of in-vitro cytotoxic effect of 5-FU loaded-chitosan nanoparticles against spheroid models.. PubMed. 4(10). 23 indexed citations
16.
Singh, Mandip, et al.. (2017). Smart thermosensitive liposomes for effective solid tumor therapy and in vivo imaging. PLoS ONE. 12(9). e0185116–e0185116. 24 indexed citations
17.
Krishnan, Sunil, et al.. (2016). Pharmacokinetic, biodistribution and therapeutic efficacy of 5-fluorouracil-loaded pH-sensitive PEGylated liposomal nanoparticles in HCT-116 tumor bearing mouse.. PubMed. 2(1). 24 indexed citations
18.
Agyare, Edward, et al.. (2015). Cytotoxicity of 5-fluorouracil-loaded pH-sensitive liposomal nanoparticles in colorectal cancer cell lines. PubMed. 2(5). 245–252. 48 indexed citations
19.
Agyare, Edward, et al.. (2014). Delivery of Polymeric Nanoparticles to Target Vascular Diseases. PubMed. s1(1). 13 indexed citations
20.
Spencer, Shawn D., et al.. (2014). Development of a novel approach to enhance the solubility of ftibamzone formulation.. Integrative Molecular Medicine. 1(3). 61–66. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mukesh Ukawala Breakdown of academic impact, for papers by Pallavi Chand Breakdown of academic impact, for papers by Bingxiang Zhao Breakdown of academic impact, for papers by Adem Şahin Breakdown of academic impact, for papers by Wei-Lun Tang Breakdown of academic impact, for papers by Nikhil Rai Breakdown of academic impact, for papers by Pasupathi Sundaramoorthy Breakdown of academic impact, for papers by Noor Alam Breakdown of academic impact, for papers by Emilienne Soma Breakdown of academic impact, for papers by Vasanthakumar Sekar
Rankless by CCL
2026